Shareholders Equity: The sum of preferred and common equity items.
Leap Therapeutics, Inc. (LPTX) had Shareholders Equity of $60.14M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-81.41M |
|
-- |
|
-- |
|
$87.04M |
|
$-87.04M |
|
$5.63M |
|
$-81.41M |
|
$-81.41M |
|
$-81.41M |
|
$-81.41M |
|
$-81.41M |
|
$-81.41M |
|
$-87.04M |
|
$-87.03M |
|
20.45M |
|
20.45M |
|
$-3.98 |
|
$-3.98 |
|
| Balance Sheet Financials | |
$71.60M |
|
$0.01M |
|
$1.23M |
|
$72.83M |
|
$12.68M |
|
-- |
|
-- |
|
$12.68M |
|
$60.14M |
|
$60.14M |
|
|
Shareholders Equity |
$60.14M |
25.57M |
|
| Cash Flow Statement Financials | |
$-43.75M |
|
$48.97M |
|
$-0.03M |
|
$65.50M |
|
$70.64M |
|
$5.14M |
|
$5.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.64 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-43.75M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-135.37% |
|
-135.37% |
|
-111.79% |
|
-135.37% |
|
$2.35 |
|
$-2.14 |
|
$-2.14 |
|